MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

07 DECEMBER 2017

Biom’up appoints Cécile Ferracci as Global Vice President Marketing 

Etienne Binant, Chief Executive Officer of Biom’Up, says: “I am delighted to welcome Cécile Ferracci to Biom’up as our Global Vice-President, Marketing. Her solid and diverse experience within global medical technology companies represents a crucial asset for Biom’up’s success at a key time in its history. Her inclusion in the Company’s Executive Committee will enable her to have a maximum impact on HEMOBLASTTM Bellows’ launch strategy in Europe and the United States, in close cooperation with our regional sales and marketing managers.”

Read more:

pr-06-12-17

ALL NEWS

Legal Information: HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country.
Read the instructions for use on the packaging carefully before use. CE0086: BSI - Manufacturer: Biom’up SA France.